Q9982 Flutemetamol f18 diagnostic
Also known as: PET imaging agent, amyloid imaging, flutemetamol
Positron emission tomography diagnostic radiopharmaceutical containing flutemetamol F18 for amyloid imaging.
In Plain Language
brain imaging scan; Alzheimer's test; protein buildup detector
Clinical Context
Used for positron emission tomography imaging to detect amyloid-beta accumulation in the brain for evaluation of Alzheimer's disease and cognitive disorders.
RVU Information
CPT Q9982 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Q-codes are temporary HCPCS codes used when no permanent code exists. Coverage and reimbursement vary by payer and region. Document the clinical indication and medical necessity. These codes may be replaced by permanent codes in future HCPCS updates.
Specialties
Frequently Asked Questions
What is CPT code Q9982?
CPT Q9982 (Flutemetamol f18 diagnostic) is a Q Codes code. Positron emission tomography diagnostic radiopharmaceutical containing flutemetamol F18 for amyloid imaging.
Is Q9982 covered by insurance?
Q9982 is a temporary HCPCS code. Coverage varies by payer and may change when permanent codes are assigned. Used for positron emission tomography imaging to detect amyloid-beta accumulation in the brain for evaluation of Alzheimer's disease and cognitive disorders.
When is CPT Q9982 used?
Used for positron emission tomography imaging to detect amyloid-beta accumulation in the brain for evaluation of Alzheimer's disease and cognitive disorders.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.